Clinical Trial Update: Telavancin Pharmacokinetics in Cystic Fibrosis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on telavancin pharmacokinetics in patients with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Telavancin (telavancin)

Snippet

Sponsor: Joseph L. Kuti, PharmD | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED